Tentative Date for FDA Advisory Panel Review of Cartiva SCI

FDA has tentatively scheduled a meeting of the Orthopaedic and Rehabilitation Devices Panel on April 20, 2016 to review Cartiva's Premarket Approval Application (PMA) for the Cartiva Synthetic Cartilage Implant (SCI), for the treatment of great toe osteoarthritis.

FDA recently completed a 5-day inspection of Cartiva's manufacturing operations...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us